Self tolerization in peripheral is critical to prevent autoimmune diseases including arthritis and here we focus on the role of PD-1 in tolerance induction against the antigen associated with apoptotic cellsdelivered intravenously (i.v.). We accessed delayed type hypersensitivity (DTH) reaction against hapten (TNP) as antigen specific immune response, in which the injection of TNP-apoptotic cells i.v. suppressed DTH in wild type mice but we found not in PD-1 KO mice (Figure 1). Adaptive transfer of CD8 T cells into PD-1 KO mouse from wild type mice tolerated with TNP-apoptotic cells suppresses DTH. This result shows PD-1 functions on CD8 T cells for immune suppression. Additionally we neutralized the PD-1 with antibody to determine the phase when PD-1 functions for immune tolerance by apoptotic cells, and identified PD-1 functions particularly at the initial phase of antigen specific immune response. We are further studying the mechanism of suppressive role of PD-1+ CD8 T cells that should be activated with apoptotic cells.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.